The purpose of this study was to evaluate the feasibility of robotic single-site surgery for benign ovarian tumors with the use of the Da Vinci Si Surgical platform.
Total five RSS ovarian cystectomy were performed with the Da Vinci Si Surgical platform in a single institution by one surgeon. Data about patient characteristics, indication of surgery, and perioperative outcomes were collected and analyzed.
All procedures were performed successfully. There were three cases of bilateral endometrioma and two cases of unilateral dermoid cyst. Mean operative time was 81.5 minutes (range, 65-95 minutes). No intraoperative or short term postoperative complication of any kind occurred. The median postoperative hospital stay was 2 days.
The use of Da Vinci Si Surgical platform is a feasible and safe treatment approach when used to treat benign ovarian tumors such as dermoid cyst and endometrioma with favorable surgical outcomes. Further evaluation should be performed in a large scale comparative study to comfirm benefits of robotic single site surgery in benign ovarian tumor.